+1 (224) 999-6997 info@zeemedicalbilling.com

As New year has commenced, with so many other changes healthcare practices should also be prepared for ICD-10 changes. Here the question arises, Is Your Practice Already Prepared for the New ICD-10 2022 Guidelines? Don`t worry! In this article, you can adhere to the New ICD-10 Coding Guidelines 2022.

What are ICD-10 Guidelines?

In all healthcare settings, ICD-10-CM guidelines are used to classify diagnoses, morbidities, and reasons for patient visits. Healthcare providers, billers, and coders must use these guidelines and reporting requirements as companion documents to the official version of the ICD-10-CM.  ICD-10-CM and the ICD-10 code set under the new guidelines, including new, revised, and retired codes, are updated. The Centers for Medicare and Medicaid Services (CMS) and the National Center for Health Statistics (NCHS) also implement the newly updated International Classification of Diseases, 10th Revision, Clinical Modification, and the ICD-10 code set.

New ICD-10 Codes 2022 Guidelines

Total 72,748 codes are available this year including:

  • 159 new codes
  • 32 deleted codes
  • 20 revised codes

New Codes for COVID-19 Infection

New codes are available for 2022 to report conditions secondary to COVID-19 infection:

  • J12.82: Pneumonia due to Coronavirus disease 2019 (MCC)
  • M35.81: Multisystem inflammatory syndrome (CC)
  • M35.89: Other specified system involvement of connective tissue (CC)
  • Z11.52: Encounter for screening for COVID-19
  • Z20.822: Contact with and (suspected) exposure to COVID-19
  • Z86.16: Personal history of COVID-19
  • U09.9: Post COVID-19 condition, unspecified

New codes for conditions affecting the nervous system

In this category ICD-10 now includes 10 new codes, with many of them classified as MCC or CC codes. Some of these new codes include:

  • G04.82: Acute flaccid myelitis (MCC)
  • G44.86: Cervicogenic headache
  • G92.00: Immune effector cell-associated neurotoxicity syndrome, grade unspecified
  • G92.01: Immune effector cell-associated neurotoxicity syndrome, grade 1
  • G92.02: Immune effector cell-associated neurotoxicity syndrome, grade 2
  • G92.03: Immune effector cell-associated neurotoxicity syndrome, grade 3 (CC)
  • G92.04: Immune effector cell-associated neurotoxicity syndrome, grade 4 (CC)
  • G92.05: Immune effector cell-associated neurotoxicity syndrome, grade 5 (CC)
  • G92.8: Other toxic encephalopathy (MCC)
  • G92.9: Unspecified toxic encephalopathy (MCC)

ICD-10 2022 New and Deleted Codes

ICD-10-CM coding guideline changes for 2022 include numerous corrections to spelling errors, as well as significant changes to diseases and conditions. Code additions and deletions are also crucial areas of change.

The table below is a noteworthy breakdown of additions and deletions to the ICD-10-CM coding guidelines for 2022.

 

ChapterAction2022 Codes2022 Code Descriptions
1New CodeA79.82Anaplasmosis [A. phagocytophilum]
2New CodeC56.3Malignant neoplasm of bilateral ovaries
2New CodeC79.63Secondary malignant neoplasm of bilateral ovaries
2New CodeC84.7AAnaplastic large cell lymphoma, ALK-negative, breast
3New CodeD55.21Anemia due to pyruvate kinase deficiency
3New CodeD55.29Anemia due to other disorders of glycolytic enzymes
3New CodeD75.83Thrombocytosis
3New CodeD75.838Other thrombocytosis
3New CodeD75.839Thrombocytosis, unspecified
3New CodeD89.44Hereditary alpha tryptasemia
4New CodeE75.244Niemann-Pick disease type A/B
5New CodeF32.ADepression, unspecified
5New CodeF78.AOther genetic related intellectual disabilities
5New CodeF78.A1SYNGAP1-related intellectual disability
5New CodeF78.A9Other genetic related intellectual disability
6New CodeG04.82Acute flaccid myelitis
6New CodeG44.86Cervicogenic headache
6New CodeG92.0Immune effector cell-associated neurotoxicity syndrome
6New CodeG92.00Immune effector cell-associated neurotoxicity syndrome, grade unspecified
6New CodeG92.01Immune effector cell-associated neurotoxicity syndrome, grade 1
6New CodeG92.02Immune effector cell-associated neurotoxicity syndrome, grade 2
6New CodeG92.03Immune effector cell-associated neurotoxicity syndrome, grade 3
6New CodeG92.04Immune effector cell-associated neurotoxicity syndrome, grade 4
6New CodeG92.05Immune effector cell-associated neurotoxicity syndrome, grade 5
6New CodeG92.8Other toxic encephalopathy
6New CodeG92.9Unspecified toxic encephalopathy
9New CodeI5ANon-ischemic myocardial injury (non-traumatic)
11New CodeK22.81Esophageal polyp
11New CodeK22.82Esophagogastric junction polyp
11New CodeK22.89Other specified disease of esophagus
11New CodeK31.AGastric intestinal metaplasia
11New CodeK31.A0Gastric intestinal metaplasia, unspecified
11New CodeK31.A1Gastric intestinal metaplasia without dysplasia
11New CodeK31.A11Gastric intestinal metaplasia without dysplasia, involving the antrum
11New CodeK31.A12Gastric intestinal metaplasia without dysplasia, involving the body (corpus)
11New CodeK31.A13Gastric intestinal metaplasia without dysplasia, involving the fundus
11New CodeK31.A14Gastric intestinal metaplasia without dysplasia, involving the cardia
11New CodeK31.A15Gastric intestinal metaplasia without dysplasia, involving multiple sites
11New CodeK31.A19Gastric intestinal metaplasia without dysplasia, unspecified site
11New CodeK31.A2Gastric intestinal metaplasia with dysplasia
11New CodeK31.A21Gastric intestinal metaplasia with low grade dysplasia
11New CodeK31.A22Gastric intestinal metaplasia with high-grade dysplasia
11New CodeK31.A29Gastric intestinal metaplasia with dysplasia, unspecified
12New CodeL24.AIrritant contact dermatitis due to friction or contact with body fluids
12New CodeL24.A0Irritant contact dermatitis due to friction or contact with body fluids, unspecified
12New CodeL24.A1Irritant contact dermatitis due to saliva
12New CodeL24.A2Irritant contact dermatitis due to fecal, urinary, or dual incontinence
12New CodeL24.A9Irritant contact dermatitis due to friction or contact with other specified body fluids
12New CodeL24.BIrritant contact dermatitis related to stoma or fistula
12New CodeL24.B0Irritant contact dermatitis related to unspecified stoma or fistula
12New CodeL24.B1Irritant contact dermatitis related to digestive stoma or fistula
12New CodeL24.B2Irritant contact dermatitis related to respiratory stoma or fistula
12New CodeL24.B3Irritant contact dermatitis related to fecal or urinary stoma or fistula
13New CodeM31.10Thrombotic microangiopathy, unspecified
13New CodeM31.11Hematopoietic stem cell transplantation-associated thrombotic microangiopathy [HSCT-TMA]
13New CodeM31.19Other thrombotic microangiopathy
13New CodeM35.05Sjögren syndrome with inflammatory arthritis
13New CodeM35.06Sjögren syndrome with peripheral nervous system involvement
13New CodeM35.07Sjögren syndrome with central nervous system involvement
13New CodeM35.08Sjögren syndrome with gastrointestinal involvement
13New CodeM35.0ASjögren syndrome with glomerular disease
13New CodeM35.0BSjögren syndrome with vasculitis
13New CodeM35.0CSjögren syndrome with dental involvement
13New CodeM45.ANon-radiographic axial spondyloarthritis
13New CodeM45.A0Non-radiographic axial spondyloarthritis of unspecified sites in spine
13New CodeM45.A1Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region
13New CodeM45.A2Non-radiographic axial spondyloarthritis of cervical region
13New CodeM45.A3Non-radiographic axial spondyloarthritis of cervicothoracic region
13New CodeM45.A4Non-radiographic axial spondyloarthritis of thoracic region
13New CodeM45.A5Non-radiographic axial spondyloarthritis of thoracolumbar region
13New CodeM45.A6Non-radiographic axial spondyloarthritis of lumbar region
13New CodeM45.A7Non-radiographic axial spondyloarthritis of lumbosacral region
13New CodeM45.A8Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region
13New CodeM45.ABNon-radiographic axial spondyloarthritis of multiple sites in spine
13New CodeM54.50Low back pain, unspecified
13New CodeM54.51Vertebrogenic low back pain
13New CodeM54.59M54.59
16New CodeP00.82Newborn affected by (positive) maternal group B streptococcus (GBS) colonization
16New CodeP09.1Abnormal findings on neonatal screening for inborn errors of metabolism
16New CodeP09.2Abnormal findings on neonatal screening for congenital endocrine disease
16New CodeP09.3Abnormal findings on neonatal screening for congenital hematologic disorders
16New CodeP09.4Abnormal findings on neonatal screening for cystic fibrosis
16New CodeP09.5Abnormal findings on neonatal screening for critical congenital heart disease
16New CodeP09.6Abnormal findings on neonatal screening for neonatal hearing loss
16New CodeP09.8Other abnormal findings on neonatal screening
16New CodeP09.9Abnormal findings on neonatal screening, unspecified
18New CodeR05.1Acute cough
18New CodeR05.2Subacute cough
18New CodeR05.3Chronic cough
18New CodeR05.4Cough syncope
18New CodeR05.8Other specified cough
18New CodeR05.9Cough, unspecified
18New CodeR35.81Nocturnal polyuria
18New CodeR35.89Other polyuria
18New CodeR45.88Nonsuicidal self-harm
18New CodeR63.30Feeding difficulties, unspecified
18New CodeR63.31Pediatric feeding disorder, acute
18New CodeR63.32Pediatric feeding disorder, chronic
18New CodeR63.39Other feeding difficulties
18New CodeR79.83Abnormal findings of blood amino-acid level
19New CodeS06.ATraumatic brain compression and herniation
19New CodeS06.A0Traumatic brain compression without herniation
19New CodeS06.A1Traumatic brain compression with herniation
19New CodeT40.71Poisoning by, adverse effect of and underdosing of cannabis (derivatives)
19New CodeT40.711Poisoning by cannabis, accidental (unintentional)
19New CodeT40.712Poisoning by cannabis, intentional self-harm
19New CodeT40.713Poisoning by cannabis, assault
19New CodeT40.714Poisoning by cannabis, undetermined
19New CodeT40.715Adverse effect of cannabis
19New CodeT40.716Underdosing of cannabis
19New CodeT40.72Poisoning by, adverse effect of and underdosing of synthetic cannabinoids
19New CodeT40.721Poisoning by synthetic cannabinoids, accidental (unintentional)
19New CodeT40.722Poisoning by synthetic cannabinoids, intentional self-harm
19New CodeT40.723Poisoning by synthetic cannabinoids, assault
19New CodeT40.724Poisoning by synthetic cannabinoids, undetermined
19New CodeT40.725Adverse effect of synthetic cannabinoids
19New CodeT40.726Underdosing of synthetic cannabinoids
19New CodeT80.82Complication of immune effector cellular therapy
20New CodeY35.899Legal intervention involving other specified means, unspecified person injured
21New CodeZ55.5Less than a high school diploma
21New CodeZ58Problems related to physical environment
21New CodeZ58.6Inadequate drinking-water supply
21New CodeZ59.00Homelessness unspecified
21New CodeZ59.01Sheltered homelessness
21New CodeZ59.02Unsheltered homelessness
21New CodeZ59.41Food insecurity
21New CodeZ59.48Other specified lack of adequate food
21New CodeZ59.81Housing instability, housed
21New CodeZ59.811Housing instability, housed, with risk of homelessness
21New CodeZ59.812Housing instability, housed, homelessness in past 12 months
21New CodeZ59.819Housing instability, housed unspecified
21New CodeZ59.89Other problems related to housing and economic circumstances
21New CodeZ71.85Encounter for immunization safety counseling
21New CodeZ91.014Allergy to mammalian meats
21New CodeZ91.51Personal history of suicidal behavior
21New CodeZ91.52Personal history of nonsuicidal self-harm
21New CodeZ92.85Personal history of cellular therapy
21New CodeZ92.850Personal history of Chimeric Antigen Receptor T-cell therapy
21New CodeZ92.858Personal history of other cellular therapy
21New CodeZ92.859Personal history of cellular therapy, unspecified
21New CodeZ92.86Personal history of gene therapy
22New CodeU09Post COVID-19 condition
22New CodeU09.9Post COVID-19 condition, unspecified

Deleted codes

19Deleted CodeT40.7XPoisoning by, adverse effect of and underdosing of cannabis (derivatives
19Deleted CodeT40.7X1Poisoning by cannabis (derivatives), accidental (unintentional)
19Deleted CodeT40.7X2Poisoning by cannabis (derivatives), intentional self-harm
19Deleted CodeT40.7X3Poisoning by cannabis (derivatives), assault
19Deleted CodeT40.7X4Poisoning by cannabis (derivatives), undetermined
19Deleted CodeT40.7X5Adverse effect of cannabis (derivatives
19Deleted CodeT40.7X6Underdosing of cannabis (derivatives)

Note: There was no change or deletion to chapters not listed above.

Implementing Diagnosis Code Changes

To ensure that claims are paid, healthcare practices should integrate the 2022 ICD-10-CM coding guideline changes into their system.

To cut the risk of Billing/medical records in ICD-10-CM updates you must teach your staff and providers about the key changes to the 2022 ICD-10-CM coding guidelines. With this, you will improve efficiency and accuracy when choosing diagnosis codes – either electronically or on paper.

To avail Zee Medical Billing Expertise and save your money by outsourcing your billing services__

Call @ +1 (224) 999-6997

Or

Get a free no-sting attached billing services quote from ZEE Medical Billing for your practice.